Qlaris Bio
PrivateLast Round
Series B
Apr 30, 2024
Total Funding Raised
$49M
Company Overview
Qlaris Bio is a biotechnology company focused on developing innovative therapies aimed at treating serious and debilitating ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qlaris Bio Comps
Public and private peers based on sector, stage, and business model.
Qlaris Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 30, 2024 | ||||
| Series A | Aug 1, 2019 |
Key People
Founding team and executive leadership
Qlaris Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series B, Series A |
| abrdn Inc. | Series B |
| Canaan Partners | Series B, Series A |
| Aberdeen | Series B |
| Mayo Clinic Ventures | Series B |
| Correlation Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Fred Guerard appointed as new President and CEO.
- Jan 27, 2026
Robert Warner appointed to the board of directors.
Qlaris Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qlaris Bio's valuation, stock price, and market status.
